Chapter/Section Purchase

1 Study Coverage
1.1 Orphan Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Orphan Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oncology
1.2.3 Gastrointestinal
1.2.4 Pulmonary
1.2.5 Neurology
1.2.6 Hematology
1.2.7 Cardio-vascular
1.2.8 Metabolic Disorders
1.2.9 Endocrinology
1.2.10 Infectious Diseases
1.2.11 Others
1.3 Market by Application
1.3.1 Global Orphan Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Orphan Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Orphan Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Orphan Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Orphan Drugs Sales by Region
2.4.1 Global Orphan Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Orphan Drugs by Region (2023-2028)
2.5 Global Orphan Drugs Revenue by Region
2.5.1 Global Orphan Drugs Revenue by Region (2017-2022)
2.5.2 Global Orphan Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Orphan Drugs Sales by Manufacturers
3.1.1 Global Top Orphan Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Orphan Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Orphan Drugs in 2021
3.2 Global Orphan Drugs Revenue by Manufacturers
3.2.1 Global Orphan Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Orphan Drugs Revenue in 2021
3.3 Global Orphan Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Orphan Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Orphan Drugs Sales by Type
4.1.1 Global Orphan Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Orphan Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Orphan Drugs Sales Market Share by Type (2017-2028)
4.2 Global Orphan Drugs Revenue by Type
4.2.1 Global Orphan Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Orphan Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Orphan Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Orphan Drugs Price by Type
4.3.1 Global Orphan Drugs Price by Type (2017-2022)
4.3.2 Global Orphan Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Orphan Drugs Sales by Application
5.1.1 Global Orphan Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Orphan Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Orphan Drugs Sales Market Share by Application (2017-2028)
5.2 Global Orphan Drugs Revenue by Application
5.2.1 Global Orphan Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Orphan Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Orphan Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Orphan Drugs Price by Application
5.3.1 Global Orphan Drugs Price by Application (2017-2022)
5.3.2 Global Orphan Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Orphan Drugs Market Size by Type
6.1.1 North America Orphan Drugs Sales by Type (2017-2028)
6.1.2 North America Orphan Drugs Revenue by Type (2017-2028)
6.2 North America Orphan Drugs Market Size by Application
6.2.1 North America Orphan Drugs Sales by Application (2017-2028)
6.2.2 North America Orphan Drugs Revenue by Application (2017-2028)
6.3 North America Orphan Drugs Market Size by Country
6.3.1 North America Orphan Drugs Sales by Country (2017-2028)
6.3.2 North America Orphan Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Orphan Drugs Market Size by Type
7.1.1 Europe Orphan Drugs Sales by Type (2017-2028)
7.1.2 Europe Orphan Drugs Revenue by Type (2017-2028)
7.2 Europe Orphan Drugs Market Size by Application
7.2.1 Europe Orphan Drugs Sales by Application (2017-2028)
7.2.2 Europe Orphan Drugs Revenue by Application (2017-2028)
7.3 Europe Orphan Drugs Market Size by Country
7.3.1 Europe Orphan Drugs Sales by Country (2017-2028)
7.3.2 Europe Orphan Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Orphan Drugs Market Size by Type
8.1.1 Asia Pacific Orphan Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Orphan Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Orphan Drugs Market Size by Application
8.2.1 Asia Pacific Orphan Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Orphan Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Orphan Drugs Market Size by Region
8.3.1 Asia Pacific Orphan Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Orphan Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Orphan Drugs Market Size by Type
9.1.1 Latin America Orphan Drugs Sales by Type (2017-2028)
9.1.2 Latin America Orphan Drugs Revenue by Type (2017-2028)
9.2 Latin America Orphan Drugs Market Size by Application
9.2.1 Latin America Orphan Drugs Sales by Application (2017-2028)
9.2.2 Latin America Orphan Drugs Revenue by Application (2017-2028)
9.3 Latin America Orphan Drugs Market Size by Country
9.3.1 Latin America Orphan Drugs Sales by Country (2017-2028)
9.3.2 Latin America Orphan Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Orphan Drugs Market Size by Type
10.1.1 Middle East and Africa Orphan Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Orphan Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Orphan Drugs Market Size by Application
10.2.1 Middle East and Africa Orphan Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Orphan Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Orphan Drugs Market Size by Country
10.3.1 Middle East and Africa Orphan Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Orphan Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Overview
11.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Company Recent Developments
11.3 Celgene
11.3.1 Celgene Corporation Information
11.3.2 Celgene Overview
11.3.3 Celgene Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celgene Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celgene Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 F. Hoffmann-La Roche Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sanofi Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Corporation Information
11.7.2 Alexion Pharmaceuticals Overview
11.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Alexion Pharmaceuticals Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alexion Pharmaceuticals Recent Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Corporation Information
11.8.2 Eli Lilly and Company Overview
11.8.3 Eli Lilly and Company Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Eli Lilly and Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly and Company Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Corporation Information
11.9.2 Novo Nordisk Overview
11.9.3 Novo Nordisk Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novo Nordisk Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novo Nordisk Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Eisai
11.11.1 Eisai Corporation Information
11.11.2 Eisai Overview
11.11.3 Eisai Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Eisai Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eisai Recent Developments
11.12 Daiichi Sankyo Company
11.12.1 Daiichi Sankyo Company Corporation Information
11.12.2 Daiichi Sankyo Company Overview
11.12.3 Daiichi Sankyo Company Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Daiichi Sankyo Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Daiichi Sankyo Company Recent Developments
11.13 Bayer
11.13.1 Bayer Corporation Information
11.13.2 Bayer Overview
11.13.3 Bayer Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Bayer Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bayer Recent Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Corporation Information
11.14.2 GlaxoSmithKline Overview
11.14.3 GlaxoSmithKline Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 GlaxoSmithKline Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 GlaxoSmithKline Recent Developments
11.15 Merck & Co
11.15.1 Merck & Co Corporation Information
11.15.2 Merck & Co Overview
11.15.3 Merck & Co Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Merck & Co Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Merck & Co Recent Developments
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Corporation Information
11.16.2 Johnson & Johnson Overview
11.16.3 Johnson & Johnson Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Johnson & Johnson Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Johnson & Johnson Recent Developments
11.17 Biogen
11.17.1 Biogen Corporation Information
11.17.2 Biogen Overview
11.17.3 Biogen Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Biogen Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Biogen Recent Developments
11.18 Takeda
11.18.1 Takeda Corporation Information
11.18.2 Takeda Overview
11.18.3 Takeda Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Takeda Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Takeda Recent Developments
11.19 Amgen
11.19.1 Amgen Corporation Information
11.19.2 Amgen Overview
11.19.3 Amgen Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Amgen Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Orphan Drugs Industry Chain Analysis
12.2 Orphan Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Orphan Drugs Production Mode & Process
12.4 Orphan Drugs Sales and Marketing
12.4.1 Orphan Drugs Sales Channels
12.4.2 Orphan Drugs Distributors
12.5 Orphan Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Orphan Drugs Industry Trends
13.2 Orphan Drugs Market Drivers
13.3 Orphan Drugs Market Challenges
13.4 Orphan Drugs Market Restraints
14 Key Findings in The Global Orphan Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer